Skip to main content

Genomic Inverse PCR for Screening of Preleukemic Cells in Newborns (GIPFEL Technology)

  • Protocol
  • First Online:
Book cover Leukemia Stem Cells

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2185))

Abstract

Recurrent chromosomal translocations define genetic subtypes of childhood leukemia and present the first hit that generates an expanded clone of preleukemic cells in the bone marrow. Most commonly, reverse transcriptase PCR is used to detect these translocations on RNA level. This technique has severe drawbacks, including sensitivity to contamination and instability of RNA. Here, we describe the genomic inverse PCR for exploration of ligated breakpoints (GIPFEL) that overcomes these pitfalls.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, Hows JM, Navarrete C, Greaves M (2002) Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A 99(12):8242–8247. https://doi.org/10.1073/pnas.112218799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Schäfer D, Olsen M, Lähnemann D, Stanulla M, Slany R, Schmiegelow K, Borkhardt A, Fischer U (2018) Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening. Blood 131(7):821–826. https://doi.org/10.1182/blood-2017-09-808402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, Greaves M (1993) In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363(6427):358–360. https://doi.org/10.1038/363358a0

  4. Gill Super HJ, Rothberg PG, Kobayashi H, Freeman AI, Diaz MO, Rowley JD (1994) Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. Blood 83(3):641–644

    Google Scholar 

  5. Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML, Felix CA (1998) T(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci U S A 95(11):6413–6418. https://doi.org/10.1073/pnas.95.11.6413

  6. Hein D, Dreisig K, Metzler M, Izraeli S, Schmiegelow K, Borkhardt A, Fischer U (2019) The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in approximately 0.6% of healthy newborns. Blood 134(16):1355–1358. https://doi.org/10.1182/blood.2019002215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pui CH, Carroll WL, Meshinchi S, Arceci RJ (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 29(5):551–565. https://doi.org/10.1200/jco.2010.30.7405

    Article  PubMed  Google Scholar 

  8. Shibata Y, Malhotra A, Dutta A (2010) Detection of DNA fusion junctions for BCR-ABL translocations by anchored ChromPET. Genome Med 2(9):70. https://doi.org/10.1186/gm191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Füller E, Schäfer D, Fischer U, Krell PF, Stanulla M, Borkhardt A, Slany RK (2014) Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL), a new method to detect translocations in leukemia. PLoS One 9(8):e104419. https://doi.org/10.1371/journal.pone.0104419

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Hein .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Hein, D., Borkhardt, A., Fischer, U. (2021). Genomic Inverse PCR for Screening of Preleukemic Cells in Newborns (GIPFEL Technology). In: Cobaleda, C., Sánchez-García, I. (eds) Leukemia Stem Cells. Methods in Molecular Biology, vol 2185. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0810-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0810-4_8

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0809-8

  • Online ISBN: 978-1-0716-0810-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics